Bone outcomes in virally suppressed youth with HIV switching to tenofovir disoproxil fumarate.
Kate BraithwaiteTristan D McPhersonYanhan ShenStephen ArpadiStephanie ShiauGillian SorourKarl-Gunter TechnauMichael T YinPublished in: Southern African journal of HIV medicine (2021)
South African ALWH switching from abacavir to TDF-based ART experienced statistically significant decreases in eGFR but not in LS and WBLH BMD. Female ALWH were more likely to experience a decrease in LS-BMD and may require closer monitoring.
Keyphrases
- antiretroviral therapy
- hiv infected
- hiv positive
- human immunodeficiency virus
- hiv aids
- small cell lung cancer
- epidermal growth factor receptor
- bone mineral density
- tyrosine kinase
- mental health
- hiv testing
- physical activity
- young adults
- hepatitis c virus
- men who have sex with men
- type diabetes
- postmenopausal women
- glycemic control
- bone loss
- skeletal muscle
- body composition